On November 16, 2021, it was reported that 15 vials of smallpox (variola) were found at Merck’s North Wales, PA laboratory in a freezer. While many people are panicking about smallpox being used as a bioweapon to unleash on Americans, as Bill Gates suggested just a couple weeks ago, the real question is – were there really vials found, or is this to invoke panic, siphon off another slush fund, and potentially prep for a future false flag event as another cover story to build the human enslavement system the globalists so desire?
Whether this is an impending false flag or a future event they wish to roll out, the timeline below paints a very interesting picture, especially the fact that the FDA has had several recent approvals of both vaccines and drug treatments for smallpox under the guise of “bioterrorism,” and continues to add the smallpox vaccines to its Strategic National Stockpile. Furthermore, this isn’t the first time that smallpox vials were allegedly found outside of the CDC. It supposedly happened in 2014, when they found 6 vials in a cardboard box, stuffed away in a cold storage room at NIH. Have these labs been experimenting with it, or were vials really found in these locations?
There are allegedly only two locations in the world who house the smallpox virus, one being the CDC and the other is Russia’s State Research Center of Virology and Biotechnology, also known as the Vector Institute, located near Novosibirsk in Siberia.
Timeline of Key Events Pertaining to Smallpox
June 22-23, 2001 Simulated Covert Smallpox Attack Dubbed “Dark Winter”
The Center for Strategic and International Studies (CSIS), Johns Hopkins Center for Civilian Biodefense Studies, Analytic Services, Inc. (ANSER) designed and initiated an exercise with former senior officials to respond to a bioterrorist smallpox attack on US citizens, and General Dennis Reimer of the Memorial Institute for the Prevention of Terrorism (MIPT) funded “Dark Winter.”
September 4, 2007 The FDA licensed Sanofi Pastuer Biologics Co.’s ACAM2000 Smallpox vaccine.
The FDA press release includes the following statements:
“Until ACAM2000 was licensed, Dryvax, manufactured by Wyeth Laboratories, Inc., was the only vaccine licensed by FDA. Routine vaccination of the American public was stopped in 1972 after the disease was eradicated from the United States. However, smallpox has the potential to be deliberately used as a weapon by terrorists. A large proportion of the population has no immunity and fatality rates could be higher than 25% if smallpox were to be released as a bioterrorist weapon.
Both vaccines are derived from the New York City Board of Health strain of vaccinia, but Dryvax was grown on the skin of calves and then essentially freeze-dried for storage. It was licensed by FDA in 1931 but is no longer manufactured. ACAM2000, a “second generation” smallpox vaccine, is derived from a clone of Dryvax, purified, and produced using modern cell culture technology.
The manufacturer has stated that the vaccine won’t be available to the public commercially, meaning it can’t be obtained from a doctor’s office. It has been purchased by the federal government for inclusion within the country’s Strategic National Stockpile, for distribution by the Department of Health and Human Services, in case it is ever needed.
Currently, designated U.S. Military personnel receive the vaccine.”
A study published on September 15, 2021 show the rates of myopericarditis, cardiovascular, and neurological adverse events among U.S. Military service members.
July 1, 2014 6 Vials of Smallpox Were Found in a Cardboard Box in a Cold Storage Room at NIH
There were a total of 327 vials found, of which 6 were smallpox. In a 2016 report by the FDA, this is what happened to those vials:
Upon discovery, the 327 vials were transferred to the NIH’s Select Agent Program Responsible Official (RO). The RO secured the materials in a CDC registered select agent laboratory on the NIH campus in Bethesda, MD. The NIH RO then immediately notified the Federal Bureau of Investigation (FBI) and the CDC’s Division of Select Agents and Toxins (DSAT) program of the discovery. The six vials labeled Variola (four vials labeled Variola and two vials labeled Alastrim, Variola minor), one vial labeled as RSSE (Russian spring-summer encephalitis virus), and nine other vials that could not be positively identified by their labels, were transferred to CDC on July 7, 2014, for evaluation.
These vials were later destroyed at CDC, under the observation of WHO officials, on February 24, 2015. Of the remaining 311 vials, 32 vials were destroyed on the NIH campus on July 9, 2014. The remaining 279 vials were transferred to the National Biodefense Analysis & Countermeasures Center and either eventually destroyed (163 vials) or retained for research (116 vials) (see Table 1 for a description of the disposition of all 327 vials).
November 2014 Bill Gates, Chimerix, Wellcome Trust, Oxford University, and FDA – Future Smallpox Treatment
In 2014, Bill Gates funded Durham-based Chimerix’s drug brincidofovir to allegedly treat Ebola. The trial was funded by the Wellcome Trust and led by Oxford University, and the FDA authorized the study. Brincidofovir was later branded as Tembexa, as the first antiviral drug used to treat smallpox, approved by the FDA in June 2021 (see below).